Measuring the effect of therapy in rheumatoid arthritis clinical trials from the patient’s perspective

References

• Heiberg T, Finset A, Uhlig T, et al. Seven year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis. Ann Rheum Dis 2005;64:191-5
   PubMed Web of Science ®Google Scholar
• Krishnan E, Fries JF. Reduction in long-term functional disability in rheumatoid arthritis from 1977 to 1998: a longitudinal study of 3035 patients. Am J Med 2003;115:371-6
   PubMed Web of Science ®Google Scholar
• Pincus T, Sokka T, Kautiainen H. Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985. Arthritis Rheum 2005;52:1009-19
   PubMed Web of Science ®Google Scholar
• Uhlig T, Heiberg T, Mowinckel P, et al. Rheumatoid arthritis is milder in the new millennium: health status in patients with rheumatoid arthritis 1994–2004. Ann Rheum Dis 2008;67:1710-15
   PubMed Web of Science ®Google Scholar
• Lehtinen K, Isomaki H. Intramuscular gold therapy is associated with long survival in patients with rheumatoid arthritis. J Rheumatol 1991;18:524-9
   PubMed Web of Science ®Google Scholar
• Choi HK, Hernan MA, Seeger JD, et al. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 2002;359:1173-7
   PubMed Web of Science ®Google Scholar
• Krause D, Schleusser B, Herborn G, et al. Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum 2000;43:14-21
   PubMed Web of Science ®Google Scholar
• Overman CL, Jurgens MS, Bossema ER, et al. Patients with rheumatoid arthritis nowadays are less psychologically distressed and physically disabled than patients two decades ago. Arthritis Care Res (Hoboken) 2013; epub ahead of print. doi:10.1002/acr.22211
   Google Scholar
• US Dept of Health, FDA, CDER C, CDRH. Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. FDA, 2009. Available at: http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf [Last accessed 17 March 2013]
   Google Scholar
• Fries JF, Spitz P, Kraines RG, et al. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45
   PubMed Web of Science ®Google Scholar
• Pincus T, Summey JA, Soraci SA Jr, et al. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983;26:1346-53
   PubMed Web of Science ®Google Scholar
• Kalyoncu U, Dougados M, Daures JP, et al. Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 2009;68:183-90
   PubMed Web of Science ®Google Scholar
• Felson DT, Anderson JJ, Boers M, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 1993;36:729-40
   PubMed Web of Science ®Google Scholar
• Geussens T, Miller C. Study design and endpoints for rheumatoid arthritis trials. In: Reid D, Miller C (eds). Clinical trials in arthritis and osteoarthritis, 2008:328
   Google Scholar
• Aletaha D, Landewe R, Karonitsch T, et al. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Rheum 2008;59:1371-7
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Reflection Paper on the Regulatory Guidance for the Use of Health-Related Quality of Life (HRQL) Measures in the Evaluation of Medicinal Products. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003637.pdf [Last accessed 17 March 2013]
   Google Scholar
• Revicki DA, Osoba D, Fairclough D, et al. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res 2000;9:887-900
   PubMed Web of Science ®Google Scholar
• The Health-Related Subjective Measurements Working Group of the Societe Francaise de Statistique/Biopharmacie & Sante. The European regulatory issues on quality of life assessment group guidance: some critical comments. Drug Inform J 2003;37:355-6
   Web of Science ®Google Scholar
• Critical Path Institute. Patient Reported Outcomes Consortium. Available at: http://www.c-path.org/PRO.cfm [Last accessed 15 April 2013]
   Google Scholar
• Gossec L, Dougados M, Rincheval N, et al. Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. Ann Rheum Dis 2009;68:1680-5
   PubMed Web of Science ®Google Scholar
• Sanderson T, Morris M, Calnan M, et al. Patient perspective of measuring treatment efficacy: the rheumatoid arthritis patient priorities for pharmacologic interventions outcomes. Arthritis Care Res (Hoboken) 2010;62:647-56
   PubMed Web of Science ®Google Scholar
• Hewlett S, Carr M, Ryan S, et al. Outcomes generated by patients with rheumatoid arthritis: how important are they? Musculoskeletal Care 2005;3:131-42
   PubMedGoogle Scholar
• Ahlmen M, Nordenskiold U, Archenholtz B, et al. Rheumatology outcomes: the patient’s perspective. A multicentre focus group interview study of Swedish rheumatoid arthritis patients. Rheumatology (Oxford) 2005;44:105-10
   PubMed Web of Science ®Google Scholar
• Lutze U, Archenholtz B. The impact of arthritis on daily life with the patient perspective in focus. Scand J Caring Sci 2007;21:64-70
   PubMed Web of Science ®Google Scholar
• Sanderson T, Morris M, Calnan M, et al. What outcomes from pharmacologic treatments are important to people with rheumatoid arthritis? Creating the basis of a patient core set. Arthritis Care Res (Hoboken) 2010;62:640-6
   PubMed Web of Science ®Google Scholar
• Whalley D, McKenna SP, de Jong Z, van der Heijde D. Quality of life in rheumatoid arthritis. Br J Rheumatol 1997;36:884-8
   PubMedGoogle Scholar
• Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83
   PubMed Web of Science ®Google Scholar
• van der Kooij SM, de Vries-Bouwstra JK, Goekoop-Ruiterman YP, et al. Patient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritis. Arthritis Rheum 2009;61:4-12
   PubMed Web of Science ®Google Scholar
• Tugwell P, Idzerda L, Wells GA. Generic quality-of-life assessment in rheumatoid arthritis. Am J Manag Care 2007;13(Suppl 9):S224-36
   PubMed Web of Science ®Google Scholar
• Stamm TA, Cieza A, Coenen M, et al. Validating the International Classification of Functioning, Disability and Health Comprehensive Core Set for Rheumatoid Arthritis from the patient perspective: a qualitative study. Arthritis Rheum 2005;53:431-9
   PubMed Web of Science ®Google Scholar
• Minnock P, Breshnihan B. Pain outcome and fatigue levels reported by women with established rheumatoid arthritis. Arthritis Rheum 2004;50:abs S471
   Web of Science ®Google Scholar
• Hewlett S, Cockshott Z, Byron M, et al. Patients’ perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored. Arthritis Rheum 2005;53:697-702
   PubMed Web of Science ®Google Scholar
• Repping-Wuts H, Uitterhoeve R, van Riel P, et al. Fatigue as experienced by patients with rheumatoid arthritis (RA): a qualitative study. Int J Nurs Stud 2008;45:995-1002
   PubMed Web of Science ®Google Scholar
• Cohen SB, Emery P, Greenwald MW, et al. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum 2006;54:2793-806
   PubMed Web of Science ®Google Scholar
• Wells G, Li T, Maxwell L, et al. Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis. Ann Rheum Dis 2008;67:260-5
   PubMed Web of Science ®Google Scholar
• Wolfe F, Michaud K. Fatigue, rheumatoid arthritis, and anti-tumor necrosis factor therapy: an investigation in 24,831 patients. J Rheumatol 2004;31:2115-20
   PubMed Web of Science ®Google Scholar
• Kirwan JR, Hewlett S. Patient perspective: reasons and methods for measuring fatigue in rheumatoid arthritis. J Rheumatol 2007;34:1171-3
   PubMed Web of Science ®Google Scholar
• Pinals RS, Masi AT, Larsen RA. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981;24:1308-15
   PubMed Web of Science ®Google Scholar
• Nicklin J, Cramp F, Kirwan J, et al. Collaboration with patients in the design of patient-reported outcome measures: capturing the experience of fatigue in rheumatoid arthritis. Arthritis Care Res (Hoboken) 2010;62:1552-8
   PubMed Web of Science ®Google Scholar
• Hewlett S, Hehir M, Kirwan JR. Measuring fatigue in rheumatoid arthritis: a systematic review of scales in use. Arthritis Rheum 2007;57:429-39
   PubMed Web of Science ®Google Scholar
• Nicklin J, Cramp F, Kirwan J, et al. Measuring fatigue in rheumatoid arthritis: a cross-sectional study to evaluate the Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional questionnaire, visual analog scales, and numerical rating scales. Arthritis Care Res (Hoboken) 2010;62:1559-68
   PubMed Web of Science ®Google Scholar
• Carr A, Hewlett S, Hughes R, et al. Rheumatology outcomes: the patient’s perspective. J Rheumatol 2003;30:880-3
   PubMed Web of Science ®Google Scholar
• Goodacre L, Smith J, Meddis D, et al. Development and validation of a patient-centred Measure of Activity Limitation (MAL) in rheumatoid arthritis. Rheumatology (Oxford) 2007;46:703-8
   PubMed Web of Science ®Google Scholar
• Veehof MM, ten Klooster PM, Taal E, et al. Comparison of internal and external responsiveness of the generic Medical Outcome Study Short Form-36 (SF-36) with disease-specific measures in rheumatoid arthritis. J Rheumatol 2008;35:610-17
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services, US Food and Drug Administration. Guidance for Industry Clinical Development Programs for Drugs, Devices, and Biological Products for the Treatment of Rheumatoid Arthritis (RA). FDA, 1999. Available at: http://www.fda.gov/downloads/Drugs/Guidances/ucm071579.pdf [Last accessed 17 March 2013]
   Google Scholar
• Fex E, Larsson BM, Nived K, et al. Effect of rheumatoid arthritis on work status and social and leisure time activities in patients followed 8 years from onset. J Rheumatol 1998;25:44-50
   PubMed Web of Science ®Google Scholar
• Sokka T, Kautiainen H, Mottonen T, et al. Work disability in rheumatoid arthritis 10 years after the diagnosis. J Rheumatol 1999;26:1681-5
   PubMed Web of Science ®Google Scholar
• Wolfe F, Hawley DJ. The longterm outcomes of rheumatoid arthritis: work disability: a prospective 18 year study of 823 patients. J Rheumatol 1998;25:2108-17
   PubMed Web of Science ®Google Scholar
• Bejarano V, Quinn M, Conaghan PG, et al. Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis. Arthritis Rheum 2008;59:1467-74
   PubMed Web of Science ®Google Scholar
• Anis A, Zhang W, Emery P, et al. The effect of etanercept on work productivity in patients with early active rheumatoid arthritis: results from the COMET study. Rheumatology (Oxford) 2009;48:1283-9
   PubMed Web of Science ®Google Scholar
• Escorpizo R, Cieza A, Beaton D, et al. Content comparison of worker productivity questionnaires in arthritis and musculoskeletal conditions using the International Classification of Functioning, Disability, and Health framework. J Occup Rehabil 2009;19:382-97
   PubMed Web of Science ®Google Scholar
• Beaton D, Bombardier C, Escorpizo R, et al. Measuring worker productivity: frameworks and measures. J Rheumatol 2009;36:2100-9
   PubMed Web of Science ®Google Scholar
• Escorpizo R, Bombardier C, Boonen A, et al. Worker productivity outcome measures in arthritis. J Rheumatol 2007;34:1372-80
   PubMed Web of Science ®Google Scholar
• Hazes JM, Taylor P, Strand V, et al. Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol. Rheumatology (Oxford) 2010;49:1900-10
   PubMed Web of Science ®Google Scholar
• Kavanaugh A, Smolen JS, Emery P, et al. Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritis. Arthritis Rheum 2009;61:1592-600
   PubMed Web of Science ®Google Scholar
• Birnbaum H, Shi L, Pike C, et al. Workplace impacts of anti-TNF therapies in rheumatoid arthritis: review of the literature. Expert Opin Pharmacother 2009;10:255-69
   PubMed Web of Science ®Google Scholar
• Drewes AM, Svendsen L, Taagholt SJ, et al. Sleep in rheumatoid arthritis: a comparison with healthy subjects and studies of sleep/wake interactions. Br J Rheumatol 1998;37:71-81
   PubMedGoogle Scholar
• Abad VC, Sarinas PS, Guilleminault C. Sleep and rheumatologic disorders. Sleep Med Rev 2008;12:211-28
   PubMed Web of Science ®Google Scholar
• Genovese MC, Schiff M, Luggen M, et al. Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy. Ann Rheum Dis 2008;67:547-54
   PubMed Web of Science ®Google Scholar
• Wells GA, Li T, Kirwan JR, et al. Assessing quality of sleep in patients with rheumatoid arthritis. J Rheumatol 2009;36:2077-86
   PubMed Web of Science ®Google Scholar
• Boers M, Tugwell P, Felson DT, et al. World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol Suppl 1994;41:86-9
   PubMedGoogle Scholar
• Nicassio PM, Ormseth SR, Custodio MK, et al. A multidimensional model of fatigue in patients with rheumatoid arthritis. J Rheumatol 2012;39:1807-13
   PubMed Web of Science ®Google Scholar
• Stucki G, Cieza A, Geyh S, et al. ICF Core Sets for rheumatoid arthritis. J Rehabil Med 2004;(44 Suppl):87-93
   PubMedGoogle Scholar
• Hirsh JM, Boyle DJ, Collier DH, et al. Health literacy predicts the discrepancy between patient and provider global assessments of rheumatoid arthritis activity at a public urban rheumatology clinic. J Rheumatol 2010;37:961-6
   PubMed Web of Science ®Google Scholar
• Kwoh CK, Ibrahim SA. Rheumatology patient and physician concordance with respect to important health and symptom status outcomes. Arthritis Rheum 2001;45:372-7
   PubMed Web of Science ®Google Scholar
• Bath J, Hooper J, Giles M, et al. Patient perceptions of rheumatoid arthritis. Nurs Stand 1999;14:35-8
   PubMedGoogle Scholar
• Schneider M, Manabile E, Tikly M. Social aspects of living with rheumatoid arthritis: a qualitative descriptive study in Soweto, South Africa – a low resource context. Health Qual Life Outcomes 2008;6:54
   PubMed Web of Science ®Google Scholar
• Linde L, Sorensen J, Ostergaard M, et al. Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D [corrected] RAQoL, and HAQ in patients with rheumatoid arthritis. J Rheumatol 2008;35:1528-37
   PubMed Web of Science ®Google Scholar
• Pope JE, Khanna D, Norrie D, et al. The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials. J Rheumatol 2009;36:254-9
   PubMed Web of Science ®Google Scholar
• Huskisson EC. Measurement of pain. Lancet 1974;2:1127-31
   PubMed Web of Science ®Google Scholar
• Huskisson EC. Measurement of pain. J Rheumatol 1982;9:768-9
   PubMed Web of Science ®Google Scholar
• Sokka T. Assessment of pain in patients with rheumatic diseases. Best Pract Res Clin Rheumatol 2003;17:427-49
   PubMed Web of Science ®Google Scholar
• Rohekar G, Pope J. Test–retest reliability of patient global assessment and physician global assessment in rheumatoid arthritis. J Rheumatol 2009;36:2178-82
   PubMed Web of Science ®Google Scholar
• Wolfe F, Michaud K. Assessment of pain in rheumatoid arthritis: minimal clinically significant difference, predictors, and the effect of anti-tumor necrosis factor therapy. J Rheumatol 2007;34:1674-83
   PubMed Web of Science ®Google Scholar
• Stewart A, Ware J. Measuring Functioning and Well-being: The Medical Outcomes Study Approach. Durham: Duke University Press, 1992
   Google Scholar
• Kvien TK, Kaasa S, Smedstad LM. Performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. II. A comparison of the SF-36 with disease-specific measures. J Clin Epidemiol 1998;51:1077-86
   PubMed Web of Science ®Google Scholar
• Russell AS, Conner-Spady B, Mintz A, et al. The responsiveness of generic health status measures as assessed in patients with rheumatoid arthritis receiving infliximab. J Rheumatol 2003;30:941-7
   PubMed Web of Science ®Google Scholar
• Kosinski M, Keller SD, Hatoum HT, et al. The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: tests of data quality, scaling assumptions and score reliability. Med Care 1999;37:MS10-22
   PubMed Web of Science ®Google Scholar
• Strand V, Singh JA. Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials. Am J Manag Care 2007;13(Suppl 9):S237-51
   PubMed Web of Science ®Google Scholar
• Lati C, Guthrie LC, Ward MM. Comparison of the construct validity and sensitivity to change of the visual analog scale and a modified rating scale as measures of patient global assessment in rheumatoid arthritis. J Rheumatol 2010;37:717-22
   PubMed Web of Science ®Google Scholar
• Khanna D, Pope JE, Khanna PP, et al. The minimally important difference for the fatigue visual analog scale in patients with rheumatoid arthritis followed in an academic clinical practice. J Rheumatol 2008;35:2339-43
   PubMed Web of Science ®Google Scholar
• Cella D, Yount S, Sorensen M, et al. Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 2005;32:811-19
   PubMed Web of Science ®Google Scholar
• Hurst NP, Kind P, Ruta D, et al. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 1997;36:551-9
   PubMedGoogle Scholar